CRISPR/Cas9 technology introduced a tyrosine to an asparagine at amino acid 2334 (p.Y2334N) in exon 42. This is a variant identified in non-syndromic retinitis pigmentosa. (J:336769)
查看原文 参与反馈
CRISPR/Cas9 technology introduced a tyrosine to an asparagine at amino acid 2334 (p.Y2334N) in exon 42. This is a variant identified in non-syndromic retinitis pigmentosa. (J:336769)